The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aclaris Therapeutics, Inc. | Common | 00461U105 | 1,713 | 1,647,214 | SH | SOLE | 1,647,214 | 0 | 0 | ||
Aduro Biotech Inc | Common | 00739L101 | 14,025 | 5,118,560 | SH | SOLE | 5,118,560 | 0 | 0 | ||
Akero Therapeutics Inc | Common | 00973Y108 | 17,135 | 808,247 | SH | SOLE | 808,247 | 0 | 0 | ||
Amyris, Inc | Common | 03236M200 | 16,620 | 6,492,247 | SH | SOLE | 6,492,247 | 0 | 0 | ||
Arcutis Biotherapeutics Inc | Common | 03969K108 | 50,259 | 1,686,527 | SH | SOLE | 1,686,527 | 0 | 0 | ||
Arrowhead Pharmaceuticals Inc | Common | 04280A100 | 22,115 | 768,674 | SH | SOLE | 768,674 | 0 | 0 | ||
Ascendis Pharma A/S | ADR | 04351P101 | 225,574 | 2,003,147 | SH | SOLE | 2,003,147 | 0 | 0 | ||
Atricure Inc | Common | 04963C209 | 2,169 | 64,573 | SH | SOLE | 64,573 | 0 | 0 | ||
Aurinia Pharmaceuticals Inc. | Common | 05156V102 | 7,266 | 500,732 | SH | SOLE | 500,732 | 0 | 0 | ||
Avadel Pharmaceuticals PLC | ADR | 05337M104 | 28,389 | 3,575,424 | SH | SOLE | 3,575,424 | 0 | 0 | ||
Avrobio Inc | Common | 05455M100 | 11,168 | 717,753 | SH | SOLE | 717,753 | 0 | 0 | ||
Black Diamond Therapeutics Inc | Common | 09203E105 | 6,290 | 252,119 | SH | SOLE | 252,119 | 0 | 0 | ||
Chiasma Inc | Common | 16706W102 | 4,643 | 1,272,156 | SH | SOLE | 1,272,156 | 0 | 0 | ||
Codexis, Inc | Common | 192005106 | 16,672 | 1,493,903 | SH | SOLE | 1,493,903 | 0 | 0 | ||
Collegium Pharmaceutical Inc | Common | 19459J104 | 7,302 | 447,173 | SH | SOLE | 447,173 | 0 | 0 | ||
Constellation Pharmaceutical | Common | 210373106 | 4,410 | 140,298 | SH | SOLE | 140,298 | 0 | 0 | ||
Crinetics Pharmaceuticals Inc | Common | 22663K107 | 48,816 | 3,320,801 | SH | SOLE | 3,320,801 | 0 | 0 | ||
Cymabay Therapeutics Inc | Common | 23257D103 | 1,595 | 1,077,467 | SH | SOLE | 1,077,467 | 0 | 0 | ||
DBV Technologies S.A. | ADR | 23306J101 | 1,058 | 269,995 | SH | SOLE | 269,995 | 0 | 0 | ||
Eiger BioPharmaceuticals Inc | Common | 28249U105 | 12,181 | 1,791,257 | SH | SOLE | 1,791,257 | 0 | 0 | ||
Forty Seven Inc | Common | 34983P104 | 37,757 | 395,691 | SH | SOLE | 395,691 | 0 | 0 | ||
Galmed Pharmaceuticals Ltd | SHS | M47238106 | 2,976 | 860,103 | SH | SOLE | 860,103 | 0 | 0 | ||
Homology Medicines, Inc. | Common | 438083107 | 15,673 | 1,008,562 | SH | SOLE | 1,008,562 | 0 | 0 | ||
IGM Biosciences Inc | Common | 449585108 | 11,209 | 199,626 | SH | SOLE | 199,626 | 0 | 0 | ||
Kadmon Holdings Inc | Common | 48283N106 | 52,541 | 12,539,515 | SH | SOLE | 12,539,515 | 0 | 0 | ||
Kala Pharmaceuticals, Inc. | Common | 483119103 | 6,917 | 786,883 | SH | SOLE | 786,883 | 0 | 0 | ||
KalVista Pharmaceuticals Inc. | Common | 483497103 | 11,297 | 1,476,796 | SH | SOLE | 1,476,796 | 0 | 0 | ||
Karuna Therapeutics Inc | Common | 48576A100 | 16,106 | 223,692 | SH | SOLE | 223,692 | 0 | 0 | ||
Kiniksa Pharmaceuticals | Common | G5269C101 | 11,750 | 759,050 | SH | SOLE | 759,050 | 0 | 0 | ||
Matinas Biopharma Hldgs Inc | Common | 576810105 | 6,770 | 11,279,323 | SH | SOLE | 11,279,323 | 0 | 0 | ||
MEI Pharma Inc | Common | 55279B202 | 15,753 | 9,784,422 | SH | SOLE | 9,784,422 | 0 | 0 | ||
Menlo Therapeutics Inc. | Common | 586858102 | 10,301 | 3,843,824 | SH | SOLE | 3,843,824 | 0 | 0 | ||
Myokardia Inc | Common | 62857M105 | 15,640 | 333,621 | SH | SOLE | 333,621 | 0 | 0 | ||
Nabriva Therapeutics AG | SHS | G63637105 | 980 | 1,704,130 | SH | SOLE | 1,704,130 | 0 | 0 | ||
New Frontier Health Corp | Common | G6461G106 | 117,975 | 14,300,000 | SH | SOLE | 14,300,000 | 0 | 0 | ||
Orchard Therapeutics plc | ADS | 68570P101 | 12,253 | 1,627,225 | SH | SOLE | 1,627,225 | 0 | 0 | ||
Passage Bio Inc | Common | 702712100 | 35,116 | 2,229,587 | SH | SOLE | 2,229,587 | 0 | 0 | ||
Precision Biosciences Inc | Common | 74019P108 | 846 | 140,255 | SH | SOLE | 140,255 | 0 | 0 | ||
Revolution Medicines Inc | Common | 76155X100 | 4,371 | 199,518 | SH | SOLE | 199,518 | 0 | 0 | ||
Rocket Pharmaceuticals Inc | Common | 77313F106 | 12,006 | 860,648 | SH | SOLE | 860,648 | 0 | 0 | ||
Selecta Biosciences Inc | Common | 816212104 | 18,910 | 7,846,509 | SH | SOLE | 7,846,509 | 0 | 0 | ||
Sierra Oncology, Inc | Common | 82640U107 | 18,826 | 1,917,074 | SH | SOLE | 1,917,074 | 0 | 0 | ||
Sinovac Biotech Ltd. | SHS | P8696W104 | 38,173 | 5,900,000 | SH | SOLE | 5,900,000 | 0 | 0 | ||
Soleno Therapeutics, Inc. | Common | 834203200 | 4,811 | 2,021,377 | SH | SOLE | 2,021,377 | 0 | 0 | ||
Tricida, Inc. | Common | 89610F101 | 11,534 | 524,290 | SH | SOLE | 524,290 | 0 | 0 | ||
Trillium Therapeutics Inc | Common | 89620X506 | 8,300 | 2,054,468 | SH | SOLE | 2,054,468 | 0 | 0 | ||
Uniqure NV | Common | N90064101 | 1,088 | 22,932 | SH | SOLE | 22,932 | 0 | 0 | ||
Verastem Inc | Common | 92337C104 | 21,488 | 8,139,535 | SH | SOLE | 8,139,535 | 0 | 0 | ||
Verona Pharma PLC | ADS | 925050106 | 6,151 | 1,492,951 | SH | SOLE | 1,492,951 | 0 | 0 | ||
Xenon Pharmaceuticals Inc | Common | 98420N105 | 4,497 | 396,589 | SH | SOLE | 396,589 | 0 | 0 | ||
Zai Lab Limited | ADR | 98887Q104 | 11,434 | 222,107 | SH | SOLE | 222,107 | 0 | 0 | ||
Zogenix Inc | Common | 98978L204 | 21,978 | 888,724 | SH | SOLE | 888,724 | 0 | 0 | ||
Zymeworks Inc | Common | 98985W102 | 39,061 | 1,101,236 | SH | SOLE | 1,101,236 | 0 | 0 |